Name

RC-3095

Alternate Names

RC 3095
RC3095

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

Bombesin/gastrin releasing peptide antagonist

NSC Number

None

Primary Site

Colorectal
gastric
lung
pancreatic
prostate cancer

Histology

None

Remarks

Phase I Bomesin receptor antagonist. AEterna Laboratories.

Coding

This drug should be coded
Glossary